News

Survey: Surgeons Play to Strengths in Early Hepatocellular Cancer

Publish date: July 23, 2012

 

FROM A SYMPOSIUM SPONSORED BY THE SOCIETY OF SURGICAL ONCOLOGY

Coauthor John F.P. Bridges, Ph.D., provided financial and administrative support for the study. Dr. Nathan reported no relevant financial disclosures.

Pages

Recommended Reading

Perihilar Cholangiocarcinoma: Neoadjuvant Therapy and Liver Transplant Effective
MDedge Hematology and Oncology
FDA Announces Limited Leucovorin Recall
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
Esophageal Cancer Survival Benefit Linked to Lymphadenectomy
MDedge Hematology and Oncology
FDA Approves New Cetuximab Use and KRAS Test
MDedge Hematology and Oncology
FDA Approves REMS for Long-Acting Opioids
MDedge Hematology and Oncology
Regorafenib Lengthens Survival in Colorectal Cancer With KRAS Mutations
MDedge Hematology and Oncology
ASCO Weighs in on PSA Screening Controversy
MDedge Hematology and Oncology
FDA Approves New Bowel Prep Product for Colonoscopy
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology